Technical Analysis for PETQ - PetIQ, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical PETQ trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 2.46% | |
| MACD Bullish Signal Line Cross | Bullish | 2.46% | |
| Inside Day | Range Contraction | 2.46% | |
| Up 3 Days in a Row | Strength | 2.46% | |
| Up 4 Days in a Row | Strength | 2.46% | |
| Up 5 Days in a Row | Strength | 2.46% | |
| 20 DMA Support | Bullish | 3.40% | |
| Outside Day | Range Expansion | 3.40% | |
| Up 3 Days in a Row | Strength | 3.40% | |
| Up 4 Days in a Row | Strength | 3.40% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2020
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Manufacturing Retail Stores Pain Diabetes Control Products Antibiotics Arthritis Wellness Products E Commerce Channels Zoonoses Dirofilaria Immitis Rimadyl Wellness
Manufacturing Retail Stores Pain Diabetes Control Products Antibiotics Arthritis Wellness Products E Commerce Channels Zoonoses Dirofilaria Immitis Rimadyl Wellness
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 36.33 |
| 52 Week Low | 15.83 |
| Average Volume | 459,760 |
| 200-Day Moving Average | 26.75 |
| 50-Day Moving Average | 24.13 |
| 20-Day Moving Average | 27.64 |
| 10-Day Moving Average | 26.99 |
| Average True Range | 2.10 |
| ADX | 17.38 |
| +DI | 30.90 |
| -DI | 19.81 |
| Chandelier Exit (Long, 3 ATRs ) | 23.94 |
| Chandelier Exit (Short, 3 ATRs ) | 29.06 |
| Upper Bollinger Band | 30.37 |
| Lower Bollinger Band | 24.91 |
| Percent B (%b) | 0.72 |
| BandWidth | 19.73 |
| MACD Line | 0.73 |
| MACD Signal Line | 0.70 |
| MACD Histogram | 0.0271 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 30.92 | ||||
| Resistance 3 (R3) | 30.71 | 29.79 | 30.57 | ||
| Resistance 2 (R2) | 29.79 | 29.26 | 29.90 | 30.45 | |
| Resistance 1 (R1) | 29.31 | 28.93 | 29.55 | 29.52 | 30.34 |
| Pivot Point | 28.39 | 28.39 | 28.52 | 28.50 | 28.39 |
| Support 1 (S1) | 27.91 | 27.86 | 28.15 | 28.12 | 27.30 |
| Support 2 (S2) | 26.99 | 27.53 | 27.10 | 27.19 | |
| Support 3 (S3) | 26.51 | 26.99 | 27.07 | ||
| Support 4 (S4) | 26.72 |
